IA2030 Scorecard
—Global
Type to select a Country
Vaccine | Baseline (2019) | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
DTP3 | 86% | 81% | 85% | 84% | 85% |
PCV3 | 51% | 52% | 60% | 63% | 67% |
MCV2 | 71% | 70% | 73% | 73% | 76% |
HPVc | 12% | 12% | 14% | 21% | 28% |
The metadata for this indicator can be viewed here. The metadata typically includes the indicator's definitions, method of estimation, limitations, and sources.